Target intelligence / Profile preview

Phosphogluconate dehydrogenase pseudogene 1 (PGDP1)

Target
PGDP1
Molecular classification
Other (Pseudogene)
01

Overview

Phosphogluconate dehydrogenase pseudogene 1 (PGDP1) is annotated as a pseudogene—the genetic remnant of what was once a protein-coding gene but has lost the ability to encode a functional enzyme. Unlike its functional counterpart, PGD (phosphogluconate dehydrogenase), which catalyzes a critical step in the pentose phosphate pathway and has well-characterized roles in redox biology and metabolism, PGDP1 does not contribute to enzymatic activity, disease, or drug interactions. No evidence supports a role for PGDP1 as a therapeutic target or biomarker. Its classification as a pseudogene means it typically serves as a non-functional genomic element, although in some cases pseudogenes can have regulatory roles; however, no such function has been established for PGDP1[7]. Context: - Phosphogluconate dehydrogenase (PGD) is a well-studied *enzyme* (not a pseudogene) involved in the pentose phosphate pathway and is of metabolic and potential clinical interest in fields such as cancer[1][3][5][7]. **PGDP1 is not the same entity and does not encode this enzyme.** - Pseudogenes like PGDP1 are common in the human genome and can be useful in evolutionary studies or as molecular markers, but they are not drug targets or functional proteins. If you sought information on the *functional* phosphogluconate dehydrogenase instead, please specify PGD, not PGDP1.

Other names
PGDL1phosphogluconate dehydrogenase-like 1PGDP1

Beyond the preview

Go deeper on Phosphogluconate dehydrogenase pseudogene 1 (PGDP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphogluconate dehydrogenase pseudogene 1 (PGDP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call